title: Current State of ST-Segment Myocardial Infarction: Evidence-based Therapies and Optimal Patient Outcomes in Advanced Systems of Care.
abstract: Advances in reperfusion therapy for ST-segment elevation myocardial infarction (STEMI) provide optimal patient outcomes. Reperfusion therapies, including contemporary primary percutaneous coronary intervention, represent decades of clinical evidence development in large clinical trials and national databases. However, rapid identification of STEMI and guideline-directed management of patients across broad populations have been best achieved in advanced systems of care. Current outcomes in STEMI reflect the evolution of both clinical data and idealized health care delivery networks.
authors.affiliation: David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA; Division of Cardiology, Harbor UCLA Medical Center, 1000 West Carson Street, Torrance, CA 90509, USA.
authors.forename: Joseph L
authors.initials: JL
authors.lastname: Thomas
authors.affiliation: David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA; Division of Cardiology, Harbor UCLA Medical Center, 1000 West Carson Street, Torrance, CA 90509, USA. Electronic address: wjfrench@labiomed.org.
authors.forename: William J
authors.initials: WJ
authors.lastname: French
keywords: Antiplatelet therapies; Antithrombotic therapies; Coronary thrombectomy; Fibrinolysis; Primary percutaneous coronary intervention; ST-segment myocardial infarction; STEMI receiving center